Product Images Carvedilol Phosphate

This appears to be a table that contains variables for a medical study and their associated hazard ratios. The variables include gender (male or female), age (<65 or =65), race (black or non-black), diabetic status (diabetic or non-diabetic), ischemic status (ischemic or non-ischemic), heart rate (>70 or <70), blood pressure (>120 mmHg or <120 mmHg), and use of spironolactone (spironolactone or no spironolactone). The hazard ratios are listed on the right-hand side of the table.*

The text describes a chart that shows the change in SBP (systolic blood pressure) and DBP (diastolic blood pressure) in mmHg over time after a morning dose of medication. The chart includes data points at hours 0, 1, 2, 3, 4, 6, 12, 18 after the dose. The lines on the chart have been smoothed using a locally weighted regression smoothing methodology.*

Carvedilol phosphate is a medication that comes in the form of extended-release capsules. Each bottle contains 30 capsules and has an NDC code of 6578471313. The medication is meant to be taken once a day and is used to treat conditions like high blood pressure or heart failure. It is manufactured in Corata and the formulation may differ in some countries.*

This is prescribing information for carvedilol phosphate extended-release capsules containing 20mg of the drug per capsule. The usual dosage and precautions are listed, including keeping the medication out of reach of children and seeking medical attention in case of overdose. The manufacturer and product details are also provided.*

This is a description of a medication called Carvedilol Phosphate, which is contained in extended-release capsules of 40mg each. The recommended daily dosage is one capsule per day, and the packaging includes 30 capsules. The text also includes cautionary advice to not accept damaged capsules, keep the medication out of reach of children, and seek professional help in case of an overdose. The manufacturer of the medication is Woodward Pharma R.*

This is the product information for carvedilol phosphate extended-release capsules containing 80mg of carwall phosphates per capsule. The usual dosage and prescribing information for this medication is provided on the packaging. The capsules are intended for medical use and should be kept out of reach of children. In case of an emergency or overdose, it is recommended to seek professional help immediately. The medication is made in Canada and the product details include the number of capsules, NDC code, and manufacturer's name. There is no available information about a vantage.*